美国OTC市场Panbela Therapeutics, Inc.股价重挫44.50% 市值跌2.4万美元

市场透视11-22

北京时间2025年11月22日05时01分，美国OTC市场Panbela Therapeutics, Inc.（PBLA.us）股票出现波动，股价大幅下挫44.50%。截至发稿，该股报0.011美元/股，成交量890股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.17百万美元，每股收益-1.48美元，毛利0.00美元，市盈率-0.00倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2585121462?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-22 05:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2585121462","market":"us","top_or_hot":-1,"title":"美国OTC市场Panbela Therapeutics, Inc.股价重挫44.50% 市值跌2.4万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年11月22日05时01分，美国OTC市场Panbela Therapeutics, Inc.（PBLA.us）股票出现波动，股价大幅下挫44.50%。截至发稿，该股报0.011美元/股，成交量890股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.17百万美元，每股收益-1.48美元，毛利0.00美元，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122050101a4b25187&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场Panbela Therapeutics, Inc.股价重挫44.50% 市值跌2.4万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场Panbela Therapeutics, Inc.股价重挫44.50% 市值跌2.4万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-22 05:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122050101a4b25187&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月22日05时01分，美国OTC市场Panbela Therapeutics, Inc.（PBLA.us）股票出现波动，股价大幅下挫44.50%。截至发稿，该股报0.011美元/股，成交量890股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.17百万美元，每股收益-1.48美元，毛利0.00美元，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122050101a4b25187&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122050101a4b25187&s=b","article_id":"2585121462","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122050101a4b25187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2585121462","pubTimestamp":1763758860,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月22日05时01分，美国OTC市场Panbela Therapeutics, Inc.股票出现波动，股价大幅下挫44.50%。美国OTC市场Panbela Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。美国OTC市场Panbela Therapeutics, Inc.公司简介：Panbela Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发颠覆性疗法，用于治疗有紧急医疗需求未得到满足的患者。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技","PBLA":"Panbela Therapeutics, Inc.","BK4007":"制药"},"translate_title":"Panbela Therapeutics, Inc. 's stock price fell 44.50% in the U.S. OTC market, and its market value fell by $24,000","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBLA":1.5,"LENZ":1.5},"content_text":"北京时间2025年11月22日05时01分，美国OTC市场Panbela Therapeutics, Inc.（PBLA.us）股票出现波动，股价大幅下挫44.50%。截至发稿，该股报0.011美元/股，成交量890股，换手率0.02%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.17百万美元，每股收益-1.48美元，毛利0.00美元，市盈率-0.00倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Panbela Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Palatin Technologies, Inc.、Alps Group Inc涨幅较大，Osr Holdings, Inc.、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd.较为活跃，换手率分别为472.71%、41.76%、32.01%，振幅较大的相关个股有Palatin Technologies, Inc.、Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Osr Holdings, Inc.，振幅分别为86.39%、63.22%、49.71%。美国OTC市场Panbela Therapeutics, Inc.公司简介：Panbela Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发颠覆性疗法，用于治疗有紧急医疗需求未得到满足的患者。 本公司的管道资产是 ivospemin（SBP-101）、FlynpoviTM（依氟鸟氨酸（CPP-1X）和舒林酸）和依氟鸟氨酸（CPP-1X），它们提供了一种多目标方法来重置许多类型疾病中存在的失调生物学，例如癌症和自身免疫。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585121462","isCrawlerRequest":true}